BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 35589723)

  • 1. Noninvasive urinary protein signatures associated with colorectal cancer diagnosis and metastasis.
    Sun Y; Guo Z; Liu X; Yang L; Jing Z; Cai M; Zheng Z; Shao C; Zhang Y; Sun H; Wang L; Wang M; Li J; Tian L; Han Y; Zou S; Gao J; Zhao Y; Nan P; Xie X; Liu F; Zhou L; Sun W; Zhao X
    Nat Commun; 2022 May; 13(1):2757. PubMed ID: 35589723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and Validation of MicroRNA Profiles in Fecal Samples for Detection of Colorectal Cancer.
    Duran-Sanchon S; Moreno L; Augé JM; Serra-Burriel M; Cuatrecasas M; Moreira L; Martín A; Serradesanferm A; Pozo À; Costa R; Lacy A; Pellisé M; Lozano JJ; Gironella M; Castells A
    Gastroenterology; 2020 Mar; 158(4):947-957.e4. PubMed ID: 31622624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fecal Clostridium symbiosum for Noninvasive Detection of Early and Advanced Colorectal Cancer: Test and Validation Studies.
    Xie YH; Gao QY; Cai GX; Sun XM; Sun XM; Zou TH; Chen HM; Yu SY; Qiu YW; Gu WQ; Chen XY; Cui Y; Sun D; Liu ZJ; Cai SJ; Xu J; Chen YX; Fang JY
    EBioMedicine; 2017 Nov; 25():32-40. PubMed ID: 29033369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long non-coding RNAs LOC285194, RP11-462C24.1 and Nbla12061 in serum provide a new approach for distinguishing patients with colorectal cancer from healthy controls.
    Wang C; Yu J; Han Y; Li L; Li J; Li T; Qi P
    Oncotarget; 2016 Oct; 7(43):70769-70778. PubMed ID: 27683121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and external validation of a faecal immunochemical test-based prediction model for colorectal cancer detection in symptomatic patients.
    Cubiella J; Vega P; Salve M; Díaz-Ondina M; Alves MT; Quintero E; Álvarez-Sánchez V; Fernández-Bañares F; Boadas J; Campo R; Bujanda L; Clofent J; Ferrandez Á; Torrealba L; Piñol V; Rodríguez-Alcalde D; Hernández V; Fernández-Seara J;
    BMC Med; 2016 Aug; 14(1):128. PubMed ID: 27580745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methylated Septin9 has moderate diagnostic value in colorectal cancer detection in Chinese population: a multicenter study.
    Lu DC; Zhang QF; Li L; Luo XK; Liang B; Lu YH; Hu BL; Jiang HX
    BMC Gastroenterol; 2022 May; 22(1):232. PubMed ID: 35546391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular detection of circulating tumor cells in the peripheral blood of patients with colorectal cancer using RT-PCR: significance of the prediction of postoperative metastasis.
    Wang JY; Wu CH; Lu CY; Hsieh JS; Wu DC; Huang SY; Lin SR
    World J Surg; 2006 Jun; 30(6):1007-13. PubMed ID: 16736329
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Lin Y; Ma C; Bezabeh T; Wang Z; Liang J; Huang Y; Zhao J; Liu X; Ye W; Tang W; Ouyang T; Wu R
    Int J Cancer; 2019 Sep; 145(6):1679-1689. PubMed ID: 30720869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of carcinoembryonic antigen as an assessment tool for predicting disease severity among patients with colorectal cancer in resource-poor setting of Kwazulu-Natal, South Africa.
    Naicker YD; Moolla Z; Madiba T
    Pan Afr Med J; 2021; 39():185. PubMed ID: 34584610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. YAP Levels Combined with Plasma CEA Levels Are Prognostic Biomarkers for Early-Clinical-Stage Patients of Colorectal Cancer.
    Xu Z; Wang H; Gao L; Zhang H; Wang X
    Biomed Res Int; 2019; 2019():2170830. PubMed ID: 31886181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of autoantibody signatures as biomarkers for early detection of colorectal carcinoma.
    Chang W; Wu L; Cao F; Liu Y; Ma L; Wang M; Zhao D; Li P; Zhang Q; Tan X; Yu Y; Lou Z; Zhao J; Zhang H; Fu C; Cao G
    Clin Cancer Res; 2011 Sep; 17(17):5715-24. PubMed ID: 21771877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomarker discovery study of inflammatory proteins for colorectal cancer early detection demonstrated importance of screening setting validation.
    Qian J; Tikk K; Werner S; Balavarca Y; Saadati M; Hechtner M; Brenner H
    J Clin Epidemiol; 2018 Dec; 104():24-34. PubMed ID: 30076979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk stratification of symptomatic patients suspected of colorectal cancer using faecal and urinary markers.
    Widlak MM; Neal M; Daulton E; Thomas CL; Tomkins C; Singh B; Harmston C; Wicaksono A; Evans C; Smith S; Savage RS; Covington JA; Arasaradnam RP
    Colorectal Dis; 2018 Dec; 20(12):O335-O342. PubMed ID: 30248228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carcinoembryonic Antigen (CEA) and Hepatic Metastasis in Colorectal Cancer: Update on Biomarker for Clinical and Biotechnological Approaches.
    Campos-da-Paz M; Dórea JG; Galdino AS; Lacava ZGM; de Fatima Menezes Almeida Santos M
    Recent Pat Biotechnol; 2018; 12(4):269-279. PubMed ID: 30062978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiplex quantitation of 270 plasma protein markers to identify a signature for early detection of colorectal cancer.
    Bhardwaj M; Weigl K; Tikk K; Holland-Letz T; Schrotz-King P; Borchers CH; Brenner H
    Eur J Cancer; 2020 Mar; 127():30-40. PubMed ID: 31972396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum haptoglobin as a novel molecular biomarker predicting colorectal cancer hepatic metastasis.
    Sun L; Hu S; Yu L; Guo C; Sun L; Yang Z; Qi J; Ran Y
    Int J Cancer; 2016 Jun; 138(11):2724-31. PubMed ID: 26756179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of High-performance Biomarker Tests vs Fecal Immunochemical Test for Noninvasive Colorectal Cancer Screening.
    Lansdorp-Vogelaar I; Goede SL; Bosch LJW; Melotte V; Carvalho B; van Engeland M; Meijer GA; de Koning HJ; van Ballegooijen M
    Clin Gastroenterol Hepatol; 2018 Apr; 16(4):504-512.e11. PubMed ID: 28733262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a circulating microRNA signature for colorectal cancer detection.
    Wang J; Huang SK; Zhao M; Yang M; Zhong JL; Gu YY; Peng H; Che YQ; Huang CZ
    PLoS One; 2014; 9(4):e87451. PubMed ID: 24709885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel Stool-Based Protein Biomarkers for Improved Colorectal Cancer Screening: A Case-Control Study.
    Bosch LJW; de Wit M; Pham TV; Coupé VMH; Hiemstra AC; Piersma SR; Oudgenoeg G; Scheffer GL; Mongera S; Sive Droste JT; Oort FA; van Turenhout ST; Larbi IB; Louwagie J; van Criekinge W; van der Hulst RWM; Mulder CJJ; Carvalho B; Fijneman RJA; Jimenez CR; Meijer GA
    Ann Intern Med; 2017 Dec; 167(12):855-866. PubMed ID: 29159365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiplex screening of 275 plasma protein biomarkers to identify a signature for early detection of colorectal cancer.
    Bhardwaj M; Weigl K; Tikk K; Benner A; Schrotz-King P; Brenner H
    Mol Oncol; 2020 Jan; 14(1):8-21. PubMed ID: 31652396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.